StimNeuro: Novel Non-invasive Brain Stimulation Techniques in Neurological Rehabilitation

Sponsor
Istituto Auxologico Italiano (Other)
Overall Status
Recruiting
CT.gov ID
NCT05766059
Collaborator
(none)
36
1
2
43.7
0.8

Study Details

Study Description

Brief Summary

Paired associative stimulation (PAS) is a non-invasive brain stimulation protocol, where two stimuli (a peripheral and a cortical one, the latter delivered with transcranial magnetic stimulation - TMS) are repeatedly associated to enhance plasticity in the brain. In the present study, a new cross-modal, visuo-motor PAS protocol - called "mirror-PAS"- will be tested as a possible non-invasive brain stimulation treatment in neurological rehabilitation to promote motor recovery and pain reduction.

Participants will perform the standard PAS targeting the motor system and the recently developed mirror-PAS in two separate sessions. The investigators will compare the possible effect of the protocols in terms of neurophysiological and behavioral outcomes to identify the optimal PAS method to enhance plasticity and promote sensory-motor function.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial Magnetic Stimulation
N/A

Detailed Description

The motor recovery of the upper limb function, particularly of the hand, is challenging in neurological rehabilitation. Transcranial magnetic stimulation (TMS) is a form of non-invasive brain stimulation that can enhance motor recovery, though promoting brain plasticity of the brain.

In this study, researchers will use a TMS protocol called Paired Associative Stimulation (PAS), in which two stimuli (e.g., a cortical stimulus - delivered with TMS - and a peripheral stimulus) are repeatedly associated to promote associative plasticity in the primary motor cortex (M1).

The objective is to explore the clinical efficacy of a newly developed cross-modal PAS protocol -the so-called "mirror-PAS"- as a possible motor rehabilitation treatment in patients with upper limb motor disorders, investigating its neurophysiological and behavioural effects. The innovative aspect of mirror-PAS is to act on a more extended visuomotor network, featured by the functional properties of the mirror neuron system (MNS). Indeed, in the mirror-PAS, a visual stimulus depicting a hand movement is repeatedly paired with a TMS pulse over M1. In the healthy, this protocol was found effective in modulating neurophysiological responses of the motor cortex (i..e, MEPs), hence inducing these effects bypassing the afferent somatosensory pathway exploited by the standard PAS protocols. This may represent a clinical advantage allowing the promotion of motor recovery through the induction of a plastic reorganization in the damaged motor system by gaining access through a potentially spared MNS.

The project's first phase aims to assess the motor and neurophysiological effects of mirror-PAS in stroke patients with upper-limb hemiparesis, compared to the standard excitatory M1-PAS (whose effects are well known in the literature, even if still debated).

In the second phase, we will test the efficacy of the mirror-PAS in a population of amputated patients affected by phantom limb pain (PLP).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
In a first phase [Phase 1], the study aims to assess the motor and neurophysiological effects of a cross-modal 'mirror-PAS' protocol in stroke patients with upper-limb hemiparesis, compared to the standard excitatory M1-PAS. In a second phase of the study [Phase 2], we will test the efficacy of the aforementioned cross-modal PAS in a population of amputated patients affected by phantom limb pain (PLP).In a first phase [Phase 1], the study aims to assess the motor and neurophysiological effects of a cross-modal 'mirror-PAS' protocol in stroke patients with upper-limb hemiparesis, compared to the standard excitatory M1-PAS. In a second phase of the study [Phase 2], we will test the efficacy of the aforementioned cross-modal PAS in a population of amputated patients affected by phantom limb pain (PLP).
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Novel Non-invasive Brain Stimulation Techniques in Neurological Rehabilitation: Cross-modal Paired Associative Stimulation (PAS) Protocols to Promote Plastic Reorganization in Stroke and Phantom Limb Pain Patients
Actual Study Start Date :
Feb 8, 2023
Anticipated Primary Completion Date :
Sep 30, 2026
Anticipated Study Completion Date :
Sep 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: [Phase 1] Stroke patients with upper-limb hemiparesis

Device: Transcranial Magnetic Stimulation
The standard PAS protocol will be compared with the mirrorPAS protocol.
Other Names:
  • TMS
  • Paired associative stimulation
  • Experimental: [Phase 2] Patients with phantom limb pain (PLP)

    Device: Transcranial Magnetic Stimulation
    The standard PAS protocol will be compared with the mirrorPAS protocol.
    Other Names:
  • TMS
  • Paired associative stimulation
  • Outcome Measures

    Primary Outcome Measures

    1. Change from baseline in motor-evoked potentials (MEP) [At baseline and after the administration of the PAS protocols]

      [Phase 1, only in stroke patients] peak-to-peak MEP amplitude

    2. Change in functional mapping of phantom limb cortical areas [At baseline and after the administration of the PAS protocols]

      [Phase 2, only in PLP patients]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria for stroke patients:
    • age from 18 to 85 years

    • single, unilateral, hemispheric stroke (cortical or sub-cortical areas)

    • stroke confirmed by neuroimaging (CT or MRI)

    • stroke at least 4 months before enrollment

    • hemiparesis of the upper limb resulting from stroke or hemianesthesia clinically documented

    Exclusion criteria for stroke patients:
    • contraindications to TMS (Rossi et all, 2021)

    • other neurological conditions (e.g., Parkinson's Disease, Multiple Sclerosis, ALS)

    • other orthopedic condition that affected the hand (e.g., carpal tunnel syndrome)

    Inclusion criteria for PLP patients:
    • age from 18 to 90 years

    • amputation of one part of the upper limb at least 2 months before enrollment

    • presence of stable phantom limb pain at least 2 months prior to enrollment

    Exclusion criteria for PLP patients:
    • contraindications to TMS (Rossi et all, 2021)

    • other neurological, orthopedical or psychiatric conditions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Istituto Auxologico Italiano IRCCS Milan Lombardia Italy 20122

    Sponsors and Collaborators

    • Istituto Auxologico Italiano

    Investigators

    • Principal Investigator: Nadia Bolognini, PhD, Laboratorio di Neuropsicologia, IRCCS Istituto Auxologico Italiano

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Istituto Auxologico Italiano
    ClinicalTrials.gov Identifier:
    NCT05766059
    Other Study ID Numbers:
    • 25C212
    First Posted:
    Mar 13, 2023
    Last Update Posted:
    Mar 13, 2023
    Last Verified:
    Mar 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Istituto Auxologico Italiano
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 13, 2023